Providence Therapeutics

Grantee website Calgary, Alberta, Canada

Purpose

to develop low cost mRNA vaccines

Division

Global Health

Date

NOVEMBER 2021

Region served

GLOBAL

Committed amount

$2,118,334

Grant topic

Vaccine Development

Duration (months)

11

Grantee location

Calgary, Alberta, Canada

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.